Crinetics Pharmaceuticals Inc (CRNX) — Long-term Investment Intensity
Crinetics Pharmaceuticals Inc (CRNX) has a Long-term Investment Intensity of 0.1% as of December 2023. Long-term investments of $470.00K represent 0.1% of total assets of $635.35 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore CRNX cash flow conversion to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Crinetics Pharmaceuticals Inc Long-term Investment Intensity (2021–2023)
This chart shows how Crinetics Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2021 to 2023. As of December 2023, the intensity stands at 0.1%, reflecting long-term investments of $470.00K against total assets of $635.35 Million USD. Explore CRNX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Crinetics Pharmaceuticals Inc (2021–2023)
The table below presents the year-by-year Long-term Investment Intensity for Crinetics Pharmaceuticals Inc from 2021 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Crinetics Pharmaceuticals Inc worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.1% | $470.00K | $635.35 Million | ▼ -0.2 pp |
| 2021 | 0.3% | $1.01 Million | $351.01 Million | — |